Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests

Area of Science:

• Endocrinology
• Nuclear Medicine

Background:

• Graves' disease is the leading cause of hyperthyroidism.
• Radioactive iodine (RAI) therapy is a common treatment for Graves' disease.
• RAI therapy typically leads to permanent hypothyroidism requiring lifelong levothyroxine replacement.

Observation:

• A subset of patients develop transient hypothyroidism after RAI therapy.
• This transient hypothyroidism initially mimics permanent hypothyroidism.
• Some cases resolve to euthyroidism before progressing to permanent hypothyroidism, while others may require repeat RAI treatment.

Findings:

• The study presents five cases illustrating transient post-RAI hypothyroidism.
• Recognizing this transient phase is crucial for accurate patient management.
• Failure to identify transient hypothyroidism can lead to delayed or inappropriate treatment.

Implications:

• Increased awareness of transient post-RAI hypothyroidism is essential for clinicians.
• Timely diagnosis and management of this condition can improve patient outcomes.
• This highlights the need for individualized monitoring following RAI therapy for Graves' disease.